(Q61862272)
Statements
Phase I Study of Oral Guanabenz for Multiple Sclerosis (English)
0 references
21 April 2015
0 references
30 October 2017
0 references
2
0 references
18 year
0 references
55 year
0 references
clinical trial
No description defined